Compare MIRM & CIFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MIRM | CIFR |
|---|---|---|
| Founded | 2018 | 2021 |
| Country | United States | United States |
| Employees | N/A | 66 |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7B | 6.7B |
| IPO Year | 2019 | N/A |
| Metric | MIRM | CIFR |
|---|---|---|
| Price | $93.69 | $17.93 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 11 |
| Target Price | ★ $115.33 | $24.91 |
| AVG Volume (30 Days) | 702.8K | ★ 23.2M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 74.59 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $19,138,000.00 | N/A |
| Revenue This Year | $26.22 | $12.29 |
| Revenue Next Year | $22.04 | $240.53 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $39.18 | $2.77 |
| 52 Week High | $109.28 | $25.52 |
| Indicator | MIRM | CIFR |
|---|---|---|
| Relative Strength Index (RSI) | 48.08 | 58.95 |
| Support Level | $85.35 | $12.53 |
| Resistance Level | $98.03 | $20.53 |
| Average True Range (ATR) | 3.39 | 1.34 |
| MACD | 0.06 | 0.45 |
| Stochastic Oscillator | 20.06 | 75.56 |
Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestatic pruritus in patients with Alagille syndrome. The company is also developing treatments such as maralixibat for PFIC and ALGS, and volixibat for adult cholestatic liver diseases. Mirum currently has three approved medicines: Livmarli, Cholbam, and Ctexli.
Cipher Digital Inc is focused on high-performance computing (HPC) data center development and operations. It is engaged in developing and operating data centers designed for HPC workloads. Its operations include managing power assets and capital allocation in response to market conditions and demand for AI-related computing capacity.